Clinical Trials Directory

Trials / Conditions / Heterozygous Familial Hypercholesterolemia (HeFH)

Heterozygous Familial Hypercholesterolemia (HeFH)

7 registered clinical trials studyying Heterozygous Familial Hypercholesterolemia (HeFH) — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingQLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT07450378
Qilu Pharmaceutical Co., Ltd.Phase 3
Not Yet Recruiting"Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
NCT07427472
Assistance Publique - Hôpitaux de ParisN/A
Not Yet RecruitingA Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT07465263
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Phase 3
RecruitingThe ORIGIN-FH Study
NCT07470723
University of Wisconsin, MadisonN/A
RecruitingA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygo
NCT07058077
Merck Sharp & Dohme LLCPhase 2 / Phase 3
RecruitingA Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
NCT07491172
CRISPR Therapeutics AGPhase 1
CompletedA Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese P
NCT01824238
Merck Sharp & Dohme LLCPhase 3